Breaking News Instant updates and real-time market news.

ABC

AmerisourceBergen

$80.03

-0.5 (-0.62%)

16:56
10/05/16
10/05
16:56
10/05/16
16:56

AmerisourceBergen initiated with a Neutral at UBS

Target $87.

  • 02

    Nov

  • 06

    Nov

ABC AmerisourceBergen
$80.03

-0.5 (-0.62%)

08/26/16
LEER
08/26/16
NO CHANGE
Target $100
LEER
Outperform
AmerisourceBergen price target raised to $100 from $91 at Leerink
Leerink analyst David Larsen raised his price target for AmerisourceBergen to $100 from $91 and says he continues to be positive on the company's shares. While 2017 is a re-set year that takes into account significant generic deflation, large customer renewals that will pressure margins and incremental investments into the core infrastructure of the company, the analyst believes the headwinds are fully reflected in the EPS growth guidance and consensus estimates. Larsen expects AmerisourceBergen to benefit from an easier comparison and continued growth in specialty in 2018. He reiterates an Outperform rating on the shares.
09/19/16
MSCO
09/19/16
NO CHANGE
MSCO
Drug Distributor price targets lowered at Morgan Stanley
Morgan Stanley analyst Ricky Goldwasser sees downside to December quarter earnings for distributors due to difficult year-over-year pricing comps. The analyst nows sees branded pricie moderation down 300 bps year-over-year versus 100bps previously as some drug manufacturers may be looking for moderating pricing practices following the Epipen controversy. As a result, Goldwasswer lowered estimates to reflect moderation in branded inflation and reduced price targets on McKesson (MCK) to $185 from $221, AmerisourceBergen (ABC) to $84 from $89, and Cardinal Health (CAH) to $82 from $91.
09/27/16
COWN
09/27/16
NO CHANGE
COWN
Market Perform
Drag on drug distributors from brand inflation worries overdone, says Cowen
Cowen analyst Charles Rhyee said he views recent concerns over moderating brand inflation and their potential impact on drug distributors as "somewhat overblown," considering that he sees the issue as a 1%-2% headwind to adjusted EPS for the group. Additionally, Rhyee expects brand inflation to revert to normal levels once the current political rhetoric dies down. The analyst trimmed his price target on AmerisourceBergen (ABC) to $88 from $90, on Cardinal Health (CAH) to $86 from $89 and on McKesson (MCK) to $188 from $200 and keeps a Market Perform rating on all three stocks.
10/04/16
AVON
10/04/16
UPGRADE
Target $96
AVON
Outperform
AmerisourceBergen upgraded to Outperform from Market Perform at Avondale
Avondale analyst Greg Bolan upgraded AmerisourceBergen to Outperform saying investors should accumulate shares at these levels and maintained his $96 price target. Bolan views distributors as the least risky companies across the drug sector and selective recommends AmerisourceBergen given earnings growth acceleration.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.